Tech Company CollectionsHealth Care Companies
List of Health Care Companies
| Company Name | Description | Year Founded | Total Amount Raised |
|---|---|---|---|
Discover what 125+ personalized reports have to say about your ancestry, health, traits and more. | 2006 | $1,118,573,568 | |
410 Medical is a medical device company dedicated to developing innovative products that enable frontline medical providers to improve care. | 2013 | $38,249,992 | |
4d Molecular Therapeutics, LLC operates as a biotechnology company. The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions. 4d Molecular Therapeutics serves customers in the State of Californ | 2013 | $295,000,000 | |
9am.health redesigns all care elements into one digital service individualized around today’s reality of people’s life - always available and convenient, at prices anyone can afford even without insurance. 9am.health focuses on chronic conditions such as d | 2021 | $19,700,000 | |
Abacus Bioscience is developing a new class of immunotherapy that unleashes the power of a novel CD180 platform technology. Our Antigen-Specific Immune Accelerants (ASIA) are POTENT, SPECIFIC and DURABLE, with broad applications across infectious disease a | 2017 | $4,413,591 | |
Abata Therapeutics, a company focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients living with progressive multiple sclerosis (MS) and other severe autoimmune and inflammatory diseases. | 2021 | $95,000,000 | |
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both autoimmunity and cancer. They leverage the systematic target validation and clinical insights gained by its founders to identify new targets. Their intensive | 2020 | $59,849,992 | |
Able Health is the one platform physician organizations need to manage value-based programs. From calculating HEDIS and Medicare measures to engaging clinicians and health plans, managing value-based programs can take an army of administrators and IT staff | 2015 | Unknown | |
Pharmaceutical company, which developed Nuplazid, based in San Diego, California. | 1993 | $811,734,976 | |
Acolyte health creates automated interactive video content featuring the caregiver’s digital twin to deliver a more effective call-to-action instructional video, in multiple languages, for the 70% of patients that don’t understand their treatment plan or w | 2022 | $1,241,500 | |
ActiveHealth Management is a national leader in population health management and passionate about helping every person achieve his or her best health. They deliver personalized guidance through their analytics and insights, care management, health, lifesty | 2020 | $2,000,000 | |
Activ Surgical is a digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes, and accessibility. Its scalable and patent-protected surgical software platform technology is driven by computer vision, artificial intelligen | 2017 | $100,400,040 | |
AcuityMD provides a platform for commercializing and improving medical devices with data. The platform brings clarity to the products used to treat patients, helping medical device companies expand access in their markets. | 2019 | $38,000,000 | |
Adagio Medical, Inc. is a privately held company located in Laguna Hills, California developing innovative cryoablation technologies that create continuous, linear, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial | 2011 | $65,640,112 | |
Adagio Therapeutics is developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1, and additional potentially emergent coronaviruses. They believe that antibodies will match or exceed the potency and coverage of conventional SAR | 2020 | $466,000,000 | |
Adicet Bio, Inc. operates as a clinical-stage bio-pharmaceutical company. The Company designs and develops of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet Bio serves customers worldwide. | 2016 | $145,624,992 | |
Advanced Diabetes Supply provides diabetes testing supplies to people nationwide. Our highly trained staff and state of the art technology ensures fast and convenient home delivery anywhere in the country. | 2002 | Unknown | |
We create nanoparticle technologies that enable and improve drug uptake and retention into the cell for medical devices. | 2018 | $16,500,000 | |
Ummet clinical need: According to a 2017 FDA safety notification, the failure (of surgical navigation systems) to adequately track changes in the position of patient anatomy during surgery (''intra-operative shift'') has led to “patient deaths, serious a | 2017 | $12,295,006 | |
Adverum Biotechnologies, formerly known as Avalanche Biotechnologies, is a publicly traded (NASDAQ:ADVM) clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare disea | 2006 | $637,372,608 | |
Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers. It has exclusive licenses to oncolytic immunotherapies developed in the lab of Dr. Michael Barry of Mayo Clinic. The company was founde | 2019 | $6,149,998 | |
Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness. Aethon's unique anti-drug-peptide conjugate/MHC antibodies are intended to be employed in conjunction with TCI of RAS, EGFR, and other cancer | 2022 | $30,000,000 | |
Akoya Biosciences, Inc. operates as a biotechnology company. The Company offers end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immun | 2015 | $127,000,000 | |
Akros Medical is a developer of innovative solutions for orthopedic surgeons. The company was founded in 2014 and is headquartered in Durham, NC | 2020 | $1,060,000 | |
A-LIGN is a technology-enabled security and compliance partner that helps global organizations take a strategic approach to confidently mitigate cybersecurity risks. Our breadth and depth of expertise and A-SCEND, our proprietary compliance management plat | 2009 | $136,000,000 | |
Alignment Healthcare Partners LP provides healthcare services. The Company offers health management, research, and advisory services to hospitals. Alignment Healthcare Partners operates in the United States. | 2013 | $375,000,000 | |
Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the development of targeted antiviral t | 2018 | $396,900,000 | |
AliveCor, Inc. develops electrocardiogram recorders. The Company creates credit card-sized wireless devices that can turn mobile platforms into heart monitors. AliveCor serves clients worldwide. | 2010 | $154,284,896 | |
Allakos Inc. operates as a clinical stage bio-technology company. The Company discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory, and proliferative diseases. Allakos serves customers in the United States. | 2012 | $312,449,536 | |
Alleviate designs self-treatment systems for chronic pathologies, combining digital and physical technologies sold direct-to-consumer. It offers a complete, holistic recovery system to help people self-manage foot pain from heel pain, plantar fasciitis (PF | 2020 | $3,579,273 | |
Allogene Therapeutics, Inc. operates as a biotechnology company. The Company develops allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in the State of California. | 2017 | $651,770,368 | |
Alloplex Biotherapeutics is dedicated to exploring the higher order combinatorial space of immunomodulators to develop an effective anti-tumor vaccine. This approach is applicable to all tumor types and is particularly suited to combinations with checkpoin | 2016 | $21,200,000 | |
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners, we democratize access to tools, technologies, services, and company creation capabilities | 2017 | $128,250,000 | |
Alpha is a new healthcare services company developing a technology platform designed to enable easy, personalized access to online diagnosis and prescription treatment for some of the most common illnesses today. We’re backed by investment from Data Collec | 2017 | $35,000,000 | |
Alpha Source, Inc (DBA Alpha Isotopes) is an early stage company that has developed a new technology to create radioisotopes. This patented technology will not only allow the Company to produce widely used radioisotopes at a significantly lower cost than | 2013 | Unknown | |
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers. Alpheus Medical also provides a non-invasive drug-device combination for outpatient treatment of recurrent glioblastoma multiforme (rGBM). | 2021 | $30,000,000 | |
Alpine Immune Sciences, Inc. (AIS) focuses on developing novel protein-based cancer immunotherapies using its proprietary variant ig domain (vIgD) platform technology. The Company develops TIP technology, based on the vIgD platform, to enhance engineered c | 2015 | $325,300,000 | |
Alterome Therapeutics is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers. | 2021 | $99,000,000 | |
Alterwood Health is a managed care company that provides healthcare services to its members and providers. They promote strong doctor-patient relationships through supportive care management strategies, innovative technology, and attractive reimbursement m | 2020 | $10,445,000 | |
Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments against age-old threats to human health: high-consequence viral pathogens. | 2022 | $35,000,000 | |
Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process. Specialized cell therapies based on induced pluripotent stem cells are to be developed | 2022 | $3,000,000,000 | |
Alucent Biomedical is a biomedical company that develops a combination drug-device therapy called Natural Vascular Scaffolding (NVS) for the treatment of vascular diseases. NVS is a first-of-a-kind combination drug-device therapy designed to assist the bod | 2017 | $46,600,000 | |
The mission of Alume Biosciences is to make its proprietary nerve illumination technology available for surgeons so that patients everywhere can benefit. | 2017 | $27,672,024 | |
Alzheon is an American clinical-stage biopharmaceutical company based in Framingham, Massachusetts. The company is developing medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders. | 2013 | $138,154,880 | |
AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin. | 2020 | $148,000,000 | |
Ambrx, Inc. operates as a biopharmaceutical company. The Company develops therapeutics such as long acting proteins, bi-specifics, and antibody drug conjugates. Ambrx operates in worldwide. | 2003 | $500,948,992 | |
American Injectables is a sterile injectable manufacturer of parenteral drugs with a world-class facility focused on ready-to-use pre-filled syringes and vials. | 2020 | $10,000,000 | |
Amplicore develops injectable and minimally invasive therapeutics for musculoskeletal disorders. | 2019 | $4,000,000 | |
Amplyx Pharmaceuticals, Inc. operates as a small molecule drug development company. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. | 2006 | $198,370,000 | |
Amunix Inc. is a pharmaceutical company. The Company focuses on therapeutic drugs which offer an alternative to antibodies and small molecules. Amunix also concentrates on protein design and the discovery research process. | 2006 | $190,000,000 | |
Amwell, formerly known as American Well, is a telemedicine company based in Boston, Massachusetts, that connects patients with doctors over secure video. Amwell sells its platform as a subscription service to healthcare providers to put their medical profe | 2006 | $865,954,112 | |
Amydis is a privately-held pharmaceutical company focused on developing innovative chemistry to detect diseases that involve the presence of amyloid proteins. | 2013 | $16,185,723 | |
Ananya Health develops a medical device to treat cervical pre-cancer in the highest-burden regions of the world. | 2020 | $125,000 | |
Anavasi Diagnostics is a medical technology company that focuses on the development of molecular diagnostic testing. | 2021 | $23,500,000 | |
AndHealth helps people reverse chronic diseases. The company operates a virtual center of excellence for migraine and is soon launching others for autoimmune conditions, including rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn’s disease. An | 2021 | $57,000,000 | |
For over 17 years, Angel Medical Systems has been committed to advancing life-sustaining patient care and the long-term management of High-Risk Coronary Artery Disease through innovation, clinical science, and collaboration. Angel Medical Systems, Inc. has | 2001 | $81,859,616 | |
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. They aim to stop cancer before it starts by treating the pre-cancerous lesions caused by HP | 2012 | $140,346,016 | |
Aperiam Bio partners with enzyme engineers and distributors to create and share stabilized, solubilized, and catalytically optimized proteins. The company was founded in 2021 and is headquartered in Austin, Texas, United States. | 2021 | $3,660,002 | |
Apero Health is a tech-focused medical billing company that gives greater control to practices and patients about their medical payments. | 2019 | $150,000 | |
Apollo Medical Holdings, Inc. is a physician-centric, technology-powered, and risk-bearing healthcare management company. The Company offers a health management and healthcare delivery platform to empower the providers in its network to deliver the quality | 2001 | $334,355,808 | |
Applied Molecular Transport Inc. operates as a biotech company. The Company develops novel therapeutics to treat severe autoimmune, metabolic, and inflammatory diseases. Applied Molecular Transport serves customers in the State of California. | 2015 | $193,700,000 | |
aptihealth, inc. is a behavioral health engagement company that uses technology to seamlessly integrate physical and behavioral healthcare. Its groundbreaking platform connects medical providers, behavioral health specialists, behavioral health prescribers | 2017 | $65,000,000 | |
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases.
The Company's proprietary ARC-sparX platform separates the tumor-recognitio | 2020 | $422,000,000 | |
Archean Biologics is a biotechnology company that provides flu medication solutions for influenza. The company's formulation utilizes a basic biological system of the strain of the influenza virus and builds resistance against it to reduce morbidity and mo | 2020 | $4,499,992 | |
Arcturus Therapeutics Holdings Inc. operates as a holding company. The company, through its subsidiaries, focuses on RNA therapeutics for the treatment of diseases. Arcturus Therapeutics Holdings serves patients in the United States. | 2013 | $365,580,064 | |
Arcus Biosciences, Inc. operates as a biotechnology company. The Company discovers, develops, and commercializes immunotherapies for the treatment of cancer patients. Arcus Biosciences serves customers in the United States. | 2015 | $647,049,984 | |
Ardelyx, Inc. manufactures biotechnological drugs. The Company offers pharmaceuticals to correct mineral metabolism imbalance and metabolic disorders by modulating the function of specific transporters, channels, and receptors located on the epithelia of t | 2007 | $346,375,328 | |
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company’s most advanced in | 1997 | $390,660,000 | |
Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma. | 2022 | $350,000,000 | |
Arine optimizes medications and improves human health through data-driven clinical services. Arine focuses on improved outcomes and lower cost of care for patients. They partner world class data scientists and engineers with expert clinicians to develop an | 2017 | $40,000,000 | |
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company. The Company focuses to improve human health through the development of novel natural and synthetic bacteriophage-based therapies to treat multidrug-resistant bacterial infecti | 2019 | $251,000,000 | |
Arrogene is a developer of a cancer medical technology designed to create a new generation of nano agents capable of delivering peptide, protein, and oligonucleotide therapeutics across the blood-brain barrier. The company's technology offers a unique nano | 2007 | $7,898,323 | |
Arrowhead Pharmaceuticals, Inc. operates as a biotechnology company. The Company develops medicines that treat intractable diseases by silencing the genes. Arrowhead Pharmaceuticals offers its services in the United States. | 1989 | $449,882,880 | |
ArsenalBio’s mission is to develop efficacious and safe cellular therapies for patients with chronic diseases, initially cancer. | 2019 | $305,806,688 | |
Arterys Inc provides software solutions. The Company develops a software-as-a-service analytics platform for revolutionizing medical imaging and health care through ultra-fast cloud computing, advanced visualization, and deep learning solutions. Arterys op | 2013 | $71,716,000 | |
Asher Bio is an information technology company that specializes in the fields of CFO Office transformation, profitability, and cost management. It focuses on building and developing better immunotherapy for cancer. The company was founded in 2019 and headq | 2019 | $163,150,000 | |
Aspargo Laboratories commercialize the rights of an oral suspension spray formulation of erectile dysfunction medication Sildenafil citrate. Spray formulation offers convenient drug administration, flexible-dose titration, and accessibility for patients wi | 2020 | $67,900,000 | |
Astek Diagnostics is building a platform (Eugris) that guides physicians in prescribing appropriate antibiotics for patients with bacterial sepsis in one hour. It is done by detecting the oxygen consumption of the bacteria | 2020 | $2,380,975 | |
At Athelas, we're bringing simple, life-changing health care products to people around the globe. The future of healthcare is at the home - we are a team of technologists building the next generation of medical products at the intersection of hardware and | 2016 | $150,131,616 | |
Atriomx develops a solution that delivers deep electrophysiology insights via non-invasive clinical hardware. Atriomx is leveraging advanced data science to transform the way cardiac arrhythmias are understood and improve the way patients are treated - bef | 2020 | $11,000,000 | |
Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (X | 2014 | $143,600,000 | |
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics. | 2020 | $40,000,000 | |
Autonomix Medical is a developer of a novel technology designed to bring clarity to minimally invasive renal denervation to treat heart disease. Its technology is used to develop minimally invasive neural monitoring and treatment devices for next-generatio | 2014 | $8,874,990 | |
Avail Medsystems is a medical technology company that develops software intended to digitize physical presence in operating rooms. The company specializes in designing and manufacturing medical devices that can be utilized during procedures for video confe | 2018 | $127,932,672 | |
Rapid digital detection of infections and treatment optimization. Accurate, rapid, digital detection of infections in any bodily fluid to indicate in real-time which drugs will be most effective at the point-of-prescription. Today the US spends $20B+ on i | 2013 | $11,613,020 | |
Unique, fully interoperable and decentralized network designed by & for healthcare | 2020 | $50,000,000 | |
Tens of thousands of men each year with prostate cancer seek treatments that impact their quality of life with significant risks of urinary or sexual dysfunction. At Avenda Health, we believe patients should not have to choose between treating their prosta | 2017 | $19,325,000 | |
Aventusoft L.L.C. was founded in 2007. The company's line of business includes developing or modifying computer software and packaging. | 2007 | $3,988,000 | |
Avidity Biosciences LLC operates as a biotechnology company. The Company develops and discovers novel antibody oligonucleotide conjugates therapeutics that overcome current barriers to the delivery of oligonucleotides and unlock their potential to treat a | 2013 | $347,067,840 | |
Avinger, Inc. manufactures medical devices. The Company offers surgical devices, medical instruments, apparatus, and other equipment. Avinger serves customers in the United States. | 2007 | $226,865,184 | |
Avive Solutions develops a next-generation Automated External Defibrillator (AED) and software solutions. Avive's AED enables anyone to positively impact the outcome of a Sudden Cardiac Arrest (SCA) rescue by building a more robust solution that addresses | 2017 | $33,454,000 | |
AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2018 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, an | 2020 | $30,040,000 | |
Axena Health is a women-led company dedicated to improving the lives of women with pelvic floor disorders by leveraging the power of digital technology. | 2023 | $51,800,000 | |
Babson Diagnostics is an operator of a healthcare technology company dedicated to bringing diagnostic blood testing to the retail pharmacy counter. The company develops a model for the blood test that requires only one-tenth of the sample size of tradition | 2017 | $44,700,000 | |
Babylon Healthcare Services Limited offers web-based health care services. The Company provides health tracking and tests, medical consultations, and ancillary solutions. Babylon Healthcare Services serves customers worldwide. | 2013 | Unknown | |
Balanced is committed to helping older adults maintain vibrancy in their lives, with an exercise platform that promises community, joy, and a personalized experience. | 2021 | $6,500,000 | |
Balt USA is a manufacturing company currently based in Irvine, California, United States. It has been founded in 2017. | 2017 | Unknown | |
Adjacent to a lumbar discectomy, the Barricaid® device is designed to close large defects (|5mm) in the annulus, which often lead to disc reherniation and/or disc collapse. Barricaid is a permanent implant with two components - an occlusion component and a | 2000 | $247,794,672 | |
Baton is a technology platform that eliminates detention and dwell for truck drivers. Long haul trucks drop off and pick up loads at our network of drop zones and Baton handles pick up and delivery to and from warehouses. | 2019 | $310,000 | |
Founded in 2015 by noted entrepreneurs Eliran Malki, Irad Deutsch and Ohad Rubin, Belong.Life provides Belong – Beating Cancer Together, a free patient navigation app that allows cancer patients and their support network to explore and manage their treatme | 2014 | $40,000,000 |
Page 1 of 8